Clinical Trial Update: Maintenance Therapy With Ceplene® (Histamine) and IL-2 on Immune Response and MRD in Acute Myeloid Leukemia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating maintenance therapy with Ceplene (histamine dihydrochloride) and interleukin-2 in acute myeloid leukemia to assess immune resp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Ceplene (histamine dihydrochloride)
• Interleukin-2 (interleukin-2)

Snippet

Sponsor: Cytovia, Inc. | Conditions: Acute Myeloid Leukemia | Phase 4 | Status: COMPLETED